INT251651

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.30
First Reported 2008
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 2
Total Number 2
Disease Relevance 1.08
Pain Relevance 0

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

Golgi apparatus (C6orf25) endoplasmic reticulum (C6orf25) plasma membrane (C6orf25)
C6orf25 (Homo sapiens)
Pain Link Frequency Relevance Heat
headache 6 36.60 Quite Low
Pain 2 5.00 Very Low Very Low Very Low
Paracetamol 1 5.00 Very Low Very Low Very Low
rheumatoid arthritis 1 5.00 Very Low Very Low Very Low
Antihistamine 1 5.00 Very Low Very Low Very Low
alcohol 1 5.00 Very Low Very Low Very Low
Bioavailability 1 5.00 Very Low Very Low Very Low
backache 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Disease 23 99.74 Very High Very High Very High
Infection 52 97.96 Very High Very High Very High
Thrombocytopenia 1 95.40 Very High Very High Very High
Coagulation Disorder 1 93.84 High High
Dengue 78 84.92 Quite High
Viremia 7 84.72 Quite High
Fever 17 67.84 Quite High
Chills 4 67.44 Quite High
Pressure Volume 2 Under Development 5 67.12 Quite High
Pressure And Volume Under Development 7 56.04 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Patients with anti-IgA antibodies, intolerant of low-IgA IVIg have successfully been transitioned to subcutaneous therapy.20,29 Young children and pregnant women with PIDD have safely received subcutaneous infusions of immunoglobulin.30,31 And while little data exists on the use of subcutaneous immunoglobulin therapy in patients with significant thrombocytopenia, anticoagulant use or bleeding disorders, there is a report of the safe use of subcutaneous therapy in a child with CVID and von Willebrand disease.32

Comparative costs of immunoglobulin therapy

Negative_regulation (received) of Positive_regulation (infusions) of immunoglobulin associated with coagulation disorder, thrombocytopenia and disease
1) Confidence 0.30 Published 2010 Journal Therapeutics and Clinical Risk Management Section Body Doc Link PMC2817783 Disease Relevance 0.75 Pain Relevance 0
We suspect that focal transmission was associated with recent DENV introductions because of the 217 paired serologic specimens from positive cluster enrollees, only one revealed an elevated but declining immunoglobulin M level, which would be indicative of a recent DENV infection occurring up to 60 d prior to cluster initiation [22].
Negative_regulation (declining) of Positive_regulation (elevated) of immunoglobulin M associated with infection
2) Confidence 0.01 Published 2008 Journal PLoS Medicine Section Body Doc Link PMC2577695 Disease Relevance 0.33 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox